Sigma Planning Corp’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,650
| Closed | -$101K | – | 1295 |
|
|
2025
Q1 | $101K | Buy |
28,650
+200
| +0.7% | +$708 | ﹤0.01% | 1157 |
|
|
2024
Q4 | $90.8K | Sell |
28,450
-200
| -0.7% | -$638 | ﹤0.01% | 1131 |
|
|
2024
Q3 | $105K | Buy |
28,650
+250
| +0.9% | +$918 | ﹤0.01% | 1165 |
|
|
2024
Q2 | $133K | Buy |
28,400
+1,550
| +6% | +$7.24K | ﹤0.01% | 1121 |
|
|
2024
Q1 | $236K | Buy |
26,850
+14,975
| +126% | +$132K | 0.01% | 1063 |
|
|
2023
Q4 | $50.8K | Sell |
11,875
-6,250
| -34% | -$26.8K | ﹤0.01% | 828 |
|
|
2023
Q3 | $61.8K | Hold |
18,125
| – | – | ﹤0.01% | 1155 |
|
|
2023
Q2 | $102K | Buy |
18,125
+850
| +5% | +$4.79K | ﹤0.01% | 1148 |
|
|
2023
Q1 | $83.4K | Sell |
17,275
-25
| -0.1% | -$121 | ﹤0.01% | 1250 |
|
|
2022
Q4 | $104K | Sell |
17,300
-200
| -1% | -$1.21K | ﹤0.01% | 1196 |
|
|
2022
Q3 | $84K | Sell |
17,500
-100
| -0.6% | -$480 | ﹤0.01% | 1193 |
|
|
2022
Q2 | $100K | Hold |
17,600
| – | – | ﹤0.01% | 1210 |
|
|
2022
Q1 | $126K | Hold |
17,600
| – | – | ﹤0.01% | 1277 |
|
|
2021
Q4 | $140K | Buy |
+17,600
| New | +$140K | ﹤0.01% | 1288 |
|